Title | Therapeutic effects of paclitaxel-containing ultrasound contrast agents. |
Publication Type | Journal Article |
Year of Publication | 2006 |
Authors | Tartis, MShortencar, McCallan, J, Lum, AFH, LaBell, R, Stieger-Vanegas, SM, Matsunaga, TO, Ferrara, KW |
Journal | Ultrasound in medicine & biology |
Volume | 32 |
Issue | 11 |
Pagination | 1771-80 |
Date Published | 2006 Nov |
Keywords | Cultured, Tumor Cells |
Abstract | Drug delivery vehicles that combine ultrasonic and molecular targeting are shown to locally concentrate a drug in a region-of-interest. The drug delivery vehicles, referred to as acoustically active lipospheres (AALs), are microbubbles surrounded by a shell of oil and lipid. In a region limited to the focal area of ultrasound application, circulating AALs are deflected by radiation force to a vessel wall and can subsequently be fragmented. Ligands targeting the alphavbeta3 integrin are conjugated to the AAL shell and increase in vitro binding by 26.5-fold over nontargeted agents. Toxicity assays demonstrate that paclitaxel-containing AALs exert a greater antiproliferative effect after insonation than free paclitaxel at an equivalent concentration. Lastly, ultrasound and molecular targeting are combined to deliver a model drug to the endothelium and interstitium of chorioallantoic membrane vasculature in vivo.
|